Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Runge, J. W.
Right arrow Articles by Allen, F. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Runge, J. W.
Right arrow Articles by Allen, F. H.
NEUROLOGY 1996;46:20S-23S
© 1996 American Academy of Neurology

Emergency treatment of status epilepticus

Jeffrey W. Runge, MD and Fred H. Allen, MD

From the Department of Emergency Medicine, Carolinas Medical Center (Dr. Runge), and Carolina Neurological Clinic (Dr. Allen), Charlotte, NC.
Address correspondence and reprint requests to Dr. Jeffrey W. Runge, Carolinas Medical Center, PO Box 32861, Charlotte, NC 28232-2861.

Abstract.

Status epilepticus occurs in more than 50,000 people in the United States each year and should be considered a neurologic emergency.A variety of drugs are used to treat status epilepticus, including IV benzodiazepines, phenytoin, and barbiturates. They are all short of being ideal, primarily because of difficulties with administration or associated toxicity. Fosphenytoin, a prodrug and phosphate ester of phenytoin, was developed to overcome the drawbacks associated with IV phenytoin. With its efficacy, safety, and ease of administration, fosphenytoin is a valuable option for the treatment of status epilepticus.

NEUROLOGY 1996;46(Suppl 1): S20-S23







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by AAN Enterprises, Inc.